Epidemiology of fertility treatment use among U.S. women with liveborn infants, 1997-2004

Journal of Women's Health

Volumn 19, Issue 3, 2010, Pages 407-416

  Duwe, Kara N ^a,b   Reefhuis, Jennita ^a   Honein, Margaret A ^a   Schieve, Laura A ^a   Rasmussen, Sonja A ^a  

^a NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^b OAK RIDGE INSTITUTE FOR SCIENCE AND EDUCATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOMIFENE CITRATE;

ADULT; AMNIOCENTESIS; ARTICLE; BIRTH DEFECT; CONCEPTION; CONTROLLED STUDY; FEMALE; FEMALE FERTILITY; HISPANIC; HUMAN; INFERTILITY; INFERTILITY THERAPY; LIFESTYLE; LIVE BIRTH; MAJOR CLINICAL STUDY; MATERNAL AGE; PREGNANCY OUTCOME; PRENATAL CARE; PREVALENCE; PRIORITY JOURNAL; UNITED STATES;

ADOLESCENT; ADULT; BIRTH RATE; CLOMIPHENE; FEMALE; FERTILITY AGENTS, FEMALE; HUMANS; LIVE BIRTH; PREGNANCY; REPRODUCTIVE TECHNIQUES, ASSISTED; UNITED STATES;

EID: 77950226396     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.2009.1499     Document Type: Article

References (57)

1. Chandra A, Martinez GM, Mosher WD, Abma JC, Jones J. Fertility, family planning, and reproductive health of U.S. women: Data from the 2002 National Survey of Family Growth. National Center for Health Statistics. Vital Health Stat 2005;23:1-160.
2. Centers for Disease Control and Prevention, American Society for Reproductive Medicine, Society for Assisted Reproductive Technology. 2006 Assisted Reproductive Technology Success Rates: National summary and fertility clinic reports. Atlanta: Centers for Disease Control and Prevention, 2008. Available at www.cdc.gov/ART/ART2006/ 508PDF/2006ART.pdf Accessed August 17, 2009.
3. Reynolds MA, Schieve LA, Martin JA, Jeng G, Macaluso M. Trends in multiple births conceived using assisted reproductive technology, United States, 1997-2000. Pediatrics 2003; 111:1159-1162.
4. Schieve LA, Rasmussen SA, Buck GM, Schendel DE, Reynolds MA, Wright VC. Are children born after assisted reproductive technology at increased risk for adverse health outcomes? Obstet Gynecol 2004;103:1154-1163.
5. Reddy UM, Wapner RJ, Rebar RW, Tasca RJ. Infertility, assisted reproductive technology, and adverse pregnancy outcomes. Obstet Gynecol 2007;109:967-977.
6. Reynolds MA, Schieve LA. Trends in embryo transfer practices and multiple gestation for IVF procedures in the USA, 1996-2002. Hum Reprod 2006;21:694-700.
7. Schieve LA, Cohen B, Nannini A, et al. A population-based study of maternal and perinatal outcomes associated with assisted reproductive technology in Massachusetts. Matern Child Health J 2007;11:517-525.
8. Schieve LA, Meikle SF, Ferre C, Peterson HB, Jeng G, Wilcox LS. Low and very low birth weight in infants conceived with use of assisted reproductive technology. N Engl J Med 2002; 346:731-737.
9. Wang YA, Sullivan EA, Black D, et al. Preterm birth and low birth weight after assisted reproductive technology-related pregnancy in Australia between 1996 and 2000. Fertil Steril 2005;83:1650-1658.
10. Helmerhorst FM, Perquin DAM, Donker D, Keirse MJNC. Perinatal outcome of singletons and twins after assisted conception: A systematic review of controlled studies. BMJ 2004;328:261-265.
11. Jackson RA, Gibson KA, Wu YW, Croughan MS. Perinatal outcomes in singletons following in vitro fertilization: A meta-analysis. Obstet Gynecol 2004;103:551-563.
12. Dhont M, de Neubourg F, Van Der Elst J, De Sutter P. Perinatal outcome of pregnancies after assisted reproduction: A case-control study. J Assist Reprod Genet 1997;14:575-580.
13. MacDorman MF, Martin JA, Matthews TJ, Hoyert DL, Ventura SJ. Explaining the 2001-2002 infant mortality increase: Data from the linked birth/infant death data set. Natl Vital Stat Rep 2005;53:1-24.
14. Zhu JL, Basso O, Obel C, Bille C, Olsen J. Infertility, infertility treatment, and congenital malformations: Danish national birth cohort. BMJ 2006;333:679-683.
15. Buckett WM, Chian R, Holzer H, Dean N, Usher R, Tan SL. Obstetric outcomes and congenital abnormalities after in vitro maturation, in vitro fertilization, and intracytoplasmic sperm injection. Obstet Gynecol 2007;110: 885-891.
16. Hansen M, Bower C, Milne E, de Klerk N, Kurinczuk JJ. Assisted reproductive technologies and the risk of birth defects-A systematic review. Hum Reprod 2004;20: 328-338.
17. Reefhuis J, Honein MA, Schieve LA, et al. Assisted reproductive technology and major structural birth defects in the United States. Hum Reprod 2009;24:360-366.
18. Kallen B, Olausson PO, Nygren KG. Neonatal outcome in pregnancies from ovarian stimulation. Obstet Gynecol 2002; 100:414-419.
19. Kousta E, White DM, Franks S. Modern use of clomiphene citrate in induction of ovulation. Hum Reprod Update 1997; 3:359-365.
20. Corchia C, Mastroiacovo P, Lanni R, Mannazzu R, Curro V, Fabris C. What proportion of multiple births are due to ovulation induction? A register-based study in Italy. Am J Public Health 1996;86:851-854.
21. The Practice Committee of the America Society for Reproductive Medicine. Use of clomiphene citrate in women. Fertil Steril 2003;80:1302-1307
22. Sovino H, Sir-Petermann T, Devoto L. Clomiphene citrate and ovulation induction. Reprod Biomed Online 2002;4:303-310. Available at www.rbmonline.com/Article/47
23. Kapiteijn K, de Bruijn CS, de Boer E, et al. Does subfertility explain the risk of poor perinatal outcome after IVF and ovarian hyperstimulation? Hum Reprod 2006;21:3228-3234.
24. National Center for Health Statistics. 2003 Revisions of the U.S. Standard Certificates of Live Birth and Death and the Fetal Death Report. Available at www.cdc.gov/nchs/vital- certs-rev.htm Accessed January 23, 2009.
25. Snijders RJ, Sebire NJ, Nicolaides KH. Maternal age and gestational age-specific risk for chromosomal defects. Fetal Diagn Ther 1995;10:356-367.
26. Schover LR, Thomas AJ, Falcone R, Attaran M, Goldberg J. Attitudes about genetic risk of couples undergoing in-vitro fertilization. Hum Reprod 1998;13:862-866.
27. Gjerris AC, Loft A, Pinborg A, Christiansen M, Tabor A. Prenatal testing among women pregnant after assisted reproductive techniques in Denmark 1995-2000: A national cohort study. Hum Reprod 2008;23:1545-1552.
28. Geipel A, Berg C, Katalinic A, et al. Different preferences for prenatal diagnosis in pregnancies following assisted reproduction versus spontaneous conception. Reprod Biomed Online 2003;8:119-123.
29. Abu-Musa AA, Nassar AH, Usta IM. Attitude of women with IVF and spontaneous pregnancies towards prenatal screening. Hum Reprod 2008;23:2438-2443.
30. Meschede D, Lemcke B, Stussel J, Louwen F, Horst J. Strong preference for noninvasive prenatal diagnosis in women pregnant through intracytoplasmic sperm injection. Prenat Diagn 1998;18:700-705.
31. Yoon PW, Rasmussen SA, Lynberg MC, et al. The National Birth Defects Prevention Study. Public Health Rep 2001; 116(Suppl 1):32-40.
32. Rasmussen SA, Olney RS, Holmes LB, et al. The National Birth Defects Prevention Study. Guidelines for case classification for the National Birth Defects Prevention Study. Birth Defects Res A Clin Mol Teratol 2003;67:193-201.
33. National Institutes of Health. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults-The evidence report. Obes Res 1998; 6(Suppl 2):51S-209S.
34. Centers for Disease Control and Prevention. Assisted reproductive technology surveillance-United States, 2006. MMWR CDC Surveill Summ 2009;58(SS-5):1-25.
35. Henne MB, Bundorf MK. Insurance mandates and trends in infertility treatments. Fertil Steril 2008;89:66-73.
36. American Society for Reproductive Medicine. State infertility insurance laws. Available at www.asrm.org/Patients/ insur.html Accessed November 23, 2008.
37. National Conference of State Legislatures. State laws related to insurance coverage for infertility treatment. Available at www.ncsl.org/ programs/health/50infert.htm Accessed November 23, 2008.
38. Schmidt L. Effects of infertility insurance mandates on fertility. J Health Econ 2007;27:431-446.
39. Bitler M, Schmidt L. Health disparities and infertility: Impacts of state-level insurance mandates. Fertil Steril 2006; 85:858-865.
40. Andersen AN, Goossens V, Ferraretti AP, et al. Assisted reproductive technology in Europe, 2004: Results generated from European registers by ESHRE. Hum Reprod 2008;23: 756-771.
41. Hughes EG, Giacomini M. Funding in vitro fertilization treatment for persistent subfertility: The pain and the politics. Fertil Steril 2001;76:431-442.
42. Gleicher N, Weghofer A, Barad D. A formal comparison of the practice of assisted reproductive technologies between Europe and the USA. Hum Reprod 2006;21:1945-1950.
43. Navarro JL, Castilla JA, Martinez L, Hernandez E, Fontes J. Coverage and current practice patterns regarding assisted reproduction techniques. Eur J Obstet Gynecol 2008;138: 3-9.
44. Rich-Edwards JW, Spiegelman D, Garland M, et al. Physical activity, body mass index, and ovulatory disorder infertility. Epidemiology 2008;13:184-190.
45. Sarwer DB, Allison KC, Gibbons LM, et al. Pregnancy and obesity: A review and agenda for future research. J Womens Health 2006;15:720-733.
46. Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Consensus on infertility treatment related to polycystic ovary syndrome. Hum Reprod 2008;23:462-477.
47. Elimian A, Demsky M, Figueroa R, et al. The influence of IVF, multiple gestation, and miscarriage on the acceptance of genetic amniocentesis. Prenat Diagn 2003;23:501-503.
48. Tymstra T, Bajema C, Beekhurst R, Mantingh A. Women's opinions on the offer and use of prenatal diagnosis. Prenat Diagn 1991;11:893-898.
49. Corchia C, Mastroiacovo P, Lanni R, Grimaldi V, Scarano G, Baronciani D. Social and geographical inequalities in prenatal care in Italy. Prenat Diagn 1995;15:535-540.
50. Kupperman M, Gates E, Washington E. Racial-ethnic differences in prenatal diagnostic test use and outcomes: Preferences, socioeconomics or patient knowledge? Obstet Gynecol 1996;87:675-682.
51. Rowe RE, Garcia J, Davidson LL. Social and ethnic inequalities in the offer and uptake of prenatal screening and diagnosis in the U.K.: A systematic review. Public Health 2004;118:177-189.
52. Khoshnood B, Blondel B, de Vigan C, Breart G. Socioeconomic barriers to informed decision making regarding maternal serum screening for Down syndrome: Results of the French National Perinatal Survey of 1998. Am J Public Health 2004;94:484-491.
53. ACOG Practice Bulletin No. 77: Screening for fetal chromosome abnormalities. Obstet Gynecol 2007;109:217-228.
54. Baruch S, Kaufman D, Hudson KL. Genetic testing of embryos: Practices and perspectives of U.S. in vitro fertilization clinics. Fertil Steril 2008;89:1053-1058.
55. Katz MG, Fitzgerald L, Bankier A, Savulescu J, Cram DS. Issues and concerns of couples presenting for preimplantation genetic diagnosis (PGD). Prenat Diagn 2002;22:1117-1122.
56. Pergament E. Preimplantation diagnosis: A patient perspective. Prenat Diagn 1991;11:493-495.
57. Cogswell M, Bitsko R, Anderka A, et al. Control selection and participation in an ongoing, population-based, case-control study of birth defects, The National Birth Defects Prevention Study. Am J Epidemiol 2009;170:975-985.